How Vigor Supports Medical Practices with GLP-1s
At Vigor Compounding, we partner with medical practices across the country to provide compounded GLP-1 medications, including semaglutide and tirzepatide, with a focus on quality, compliance, and patient results.
Our CEO, Edward Zatta, RPh, brings over 30 years of pharmaceutical experience to Vigor Compounding. A registered pharmacist and expert in compounding, Edward:
- Pioneered sterile infusion therapy protocols
- Founded a 503B Outsourcing Facility, and currently runs the 503A compounding pharmacy
- Is highly respected for his expertise in FDA regulations and pharmacy compliance
With Edward’s leadership, Vigor Compounding ensures safe, reliable delivery, patient-ready GLP-1 medications to both providers and their patients nationwide.
Vigor Compounding is Licensed in 31 States
Results to Expect
OUR GLP-1 PROGRAM DELIVERS TRANSFORMATIVE OUTCOMES FOR PATIENTS AND PRACTICES ALIKE.